Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 46NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 7Myeloid 7Classical hematology 7Lymphoid 6Plasma cell 1

Conditions

Multiple Myeloma 1112Recurrence 195Neoplasms 89Lymphoma 89Neoplasms, Plasma Cell 88Lymphoma, Non-Hodgkin 86Leukemia, Myeloid, Acute 53Hematologic Neoplasms 51Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia 37Myelodysplastic Syndromes 33Lymphoma, Large B-Cell, Diffuse 31Hodgkin Disease 31Immunoglobulin Light-chain Amyloidosis 30Breast Neoplasms 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hematologic Diseases 25Prostatic Neoplasms 19Paraproteinemias 19Lymphoma, B-Cell 19Amyloidosis 19Lymphoma, Mantle-Cell 18Ovarian Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Waldenstrom Macroglobulinemia 16Lung Neoplasms 16Lymphoma, Follicular 15Lymphoproliferative Disorders 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Blood Protein Disorders 14

Interventions

fludarabine 1Melphalan 1Etoposide 1Cytarabine 1Clofarabine 1Carmustine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Anemia, Aplastic × Plasma cell × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡